
ã«ããã§ãç¹å®ã§ããªãæ»å ãã300ïŒ å¢å ã調æ»ãæ±ãã声ãé«ãŸã
å èšäºã¯ãã¡ããã/Click here to read the original article.
ã«ããæ¿åºã®æ°ããªå ±åæžã«ãããšã2019幎ãã2022幎ã«ãããŠãç¹å®ã§ããªãæ»å ãã300ïŒ å¢å ããåå äžæãã«ããã«ãããæ»å ã®ç¬¬5äœã«äžæããããšãæããã«ãªã£ããäžéšã®ä¿å¥å°éå®¶ã¯ããã®æ¿å¢ãCOVID-19ã¯ã¯ãã³ãšã®é¢é£æ§ã調æ»ãããã£ããã«ãªãã¯ãã ãšè¿°ã¹ãã
ã«ããã§å¹³å寿åœãæ¥æžãããªãããç¹å®äžèœã®æ»å ããã¬ã³ãå¿èç ãCOVID-19ãäºæ ã«æ¬¡ã第5ã®æ»å ã«ãªã£ããšããæ°ããæ¿åºå ±åæžãçºè¡šãããã
ã«ããçµ±èšå±ã®å ±åæžã«ãããšã2022幎ã®ãç¹å®äžèœã®åå ãã¯ãè³åäžãåèç€ãæ ¢æ§æ°ç®¡æ¯çãèºæ°è «ã忝ãç³å°¿ç ãã€ã³ãã«ãšã³ã¶ã»èºçãæ ¢æ§èçŸæ£ã»è硬å€ãã¢ã«ããã€ããŒç ãèªæ®ºãæ»å ãšããŠæããã
ã«ããçµ±èšå±ïŒéç§°StatCanïŒã¯11æ27æ¥ãåå±ã®ãªã³ã©ã€ã³ãã¥ãŒã¹éå ±ãThe Dailyãã§ãã®å ±åæžãçºè¡šããã
ãã®å ±åæžã¯ãããã³ãã»ãµã³çŽã«æ²èŒããããã®ãšã»ãŒåãèŠåºãã§ãã«ããã®äž»èŠçŽã«æ²èŒãããïŒ ãã«ãã人ã®å¹³åäœåœã¯2022幎ã«3幎é£ç¶ã§æžå°ããããšStatCanã¯çºè¡šããïŒ ããã³ãããã¯ãå§ãŸã£ãŠä»¥æ¥ã2022幎ã«COVID-19ã§æ»äº¡ããäººã®æ°ã¯ä»ã®ã©ã®å¹Žãããå€ãã£ããã
ã«ããã®ä»£è¡šçãªæ°èã§ããããã³ãã®ã°ããŒãã»ã¢ã³ãã»ã¡ãŒã«çŽã®å¥åº·ã³ã©ã ãã¹ããã¢ã³ãã¬ã»ãã«ãŒã«æ°ã¯ãå¹³å寿åœã2019幎ã®82.3æ³ãã2022幎ã«ã¯81.3æ³ã«äžããããšã ã倧å€ãªããšããšåŒãã ã
ãã«ããã§ããã»ã©æ¥æ¿ãªäœäžãèµ·ããã®ã¯ãéå»100幎ã§2床ç®ã ããšãã«ãŒã«ã¯èšãããå®éãå¹³å寿åœã¯æ°å幎ã«ããã£ãŠçå®ã«äŒžã³ãŠããã1960幎ã«ã¯71æ³ã1980幎ã«ã¯75æ³ã2000幎ã«ã¯79æ³ããããŠ2019幎ã«ã¯82.3æ³ã§ããã
ã«ããã«ãããCOVID-19ã«ããæ»äº¡è æ°ã¯ã2020幎ã®16,313人ãã2021幎ã«ã¯14,466äººã«æžå°ããã2023幎ã®COVID-19ã«ããæ»äº¡è æ°ã¯çŽ7,000人ã«ãªãèŠèŸŒã¿ã§ãããšPicardæ°ã¯è¿°ã¹ãã
COVID-19ã«ããæ»äº¡ã¯ã2022幎ã®ã«ããã®ç·æ»äº¡æ°ã2021å¹Žãšæ¯èŒããŠ7.3ïŒ å¢å ããããšããããã¯ã«ããã®ç·æ»äº¡æ°ãæŽå²çãªæšæºã§ãã2019å¹Žãšæ¯èŒããŠ17ïŒ å¢å ããããšããããã¯ã«ãããšäžçã«ãããå¹³å寿åœã®æŽå²çãªäœäžã説æããããšã¯ã§ããªãããšãã«ãŒã«æ°ã¯è¿°ã¹ãã
ç±³åœã®å€ãã®äž»æµæŽŸãžã£ãŒããªã¹ããå ¬è¡è¡çåœå±è ãç±³åœã®å¹³å寿åœã®äœäžã調æ»ããŠããããã«ããã«ãŒã«æ°ãæ ¢æ§çŸæ£ãè¬ç©ã®éå°æåããªããªã€ãã«ããæ»äº¡ãå«ç ãäžå¥åº·ãªé£ç掻ããããŠãç¡é¢å¿ããã«ããã®å¹³å寿åœäœäžã®åå ã ãšéé£ãããããã¹ã¯ã®ãããªç·©åæªçœ®ã¯ãã¯ãäºå®äžãªããã¯ã¯ãã³æ¥çš®çã¯æ¥æ¿ã«äœäžããŠããããšåœŒã¯æžããŠããã
ããããããšãŒã«ã»ã³ãªãŒå士ãšããŒã¿ãŒã»ããã«ããŒå士ã¯ããã®å ±åæžã«å«ãŸããæãéèŠã§é©ãã¹ãäºå®ã¯ã2019幎ãã2022幎ã«ãããŠã«ããã«ããããç¹å®ã§ããªãæ»å ãã300ïŒ å¢å ããããšã ãšèããŠãããšThe Defenderã«èªã£ãã
COVID-19ã®æ©ææ²»çãããã³ã«ãéçºãã埪ç°åšå°éå»ã§ããããã«ããŒæ°ã¯ãã«ããã«ããããç¹å®äžèœã®æ»å ãã«ããæ»äº¡ã®æ¿å¢ã¯ã西æŽå»åŠã«ãããæ¿éçã§äžç©ãªå€åã衚ããŠãããšè¿°ã¹ãã
ããã³ãããã¯ä»¥åã¯ã欧米諞åœã®æ»å ã¯ããçè§£ãããŠãããã
圌ã¯ããä»ãå ããïŒ
ãCOVID-19ã¯ã¯ãã³ã®çºå£²ä»¥æ¥ãç§ãã¡ã¯åäŸã®ãªãæ»äº¡äŸãç®ã®åœããã«ããŠãããHulscherãã«ãã£ãŠçºè¡šãããå€§èŠæš¡ãªåæ€ã·ãªãŒãºã«ããã°ãCOVID-19ã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡ã®73.9ïŒ ã¯ã泚å°ã«ããåé¡ã§ãã£ããã
ããã«ããŒã¯ãã¯ã¯ãã³æ¥çš®åŸã®ã¹ãã€ã¯ã»ãããã€ã³ã«é¢é£ããå·å®³ãæ»äº¡ã調æ»ããäœçŸãã®ç ç©¶ããmRNAã¯ã¯ãã³æ¥çš®åŸã«ã¢ã¡ãªã«ããšãŒãããã®åžæ°ããæ¿åºã«å ±åãããäœçŸäžãã®æ»å·è ãåŒãåãã«åºããã
ããã¹ãŠã®æ»äº¡äŸã¯ãCOVID-19ã¯ã¯ãã³æ¥çš®ã®çšéãšæ¥ä»ã«ãã£ãŠåé¡ãããã¹ãã§ãããšããã«ããŒã¯èšãããããã§ãªãããšã蚌æãããªãéãããç¹å®äžèœã®æ»äº¡ ãã¯èŽæ»çãªCOVID-19ã¯ã¯ãã³å·å®³çå矀ã«èµ·å ãããã®ã§ããã¹ãã§ãããšããã«ããŒã¯èšãã
å ãŠã£ã¹ã³ã³ã·ã³å€§åŠå»åŠéšææã§ãããã³ãã»ã©ã€ã³COVID-19ã¯ãªãã£ã«ã«ã»ã±ã¢ã»ã¢ã©ã€ã¢ã³ã¹ã®äŒé·ã§ããã³ãŒãªãŒã¯ãCOVID-19 mRNA泚å°ããæŽå²äžã®ã©ã®è¬ç©ãã¯ã¯ãã³ãããå€ãã®æ»å·è ãæ¬§ç±³è«žåœã«ããããããšããå§åçãªèšŒæ ããããšããã£ãã§ã³ããŒãçŽã«èªã£ãã
ãªã ãç¹å®äžèœã®åå ããæ»å ã®äžäœãå ããããã«ãªã£ãã®ãããã®çãã¯åçŽæå¿«ã§ããããã®åå ãšã¯ãïŒãã³ãããã¯ã®ïŒå§ãŸã以æ¥ãäžçã®æ¿åºãã¡ãã£ã¢ãæ¯æããŠããå»çä»å ¥ã§ããã......mRNAãã©ãããã©ãŒã æè¡ã¯ãæå¹æ§ãå®å šæ§ãšãã«å€§å€±æã§ãã£ããã
ã³ãŒãªãŒæ°ãšãžã£ãŒããªã¹ãã®ã¡ã¢ãªãŒã»ãã¹ã»ãã¡ã€ãã¡ãŒæ°ã¯ç«ææ¥ããã¶ã»ãã«ãçŽã«ãäžççãªæŽå²çãªæ»äº¡çã®äžæã«ã€ããŠãæ¿åºãå ¬è¡è¡çåœå±ãç ç©¶ãã察åŠããããåŒã³ãããæèŠæžãçºè¡šããã
12æ13æ¥ããã®å°è«ã¯ãæé3250äžäººã®ãŠããŒã¯ããžã¿ãŒã蚪ããThe Hillã®ãŠã§ããµã€ãã§ã1äœã2äœãäºã人æ°èšäºãšãªã£ãã
ç±³é£åå»è¬åå±ïŒFDAïŒé·å®ã®ãããŒãã»ã«ãªãã¯11æ30æ¥ãXïŒæ§ãã€ãã¿ãŒïŒäžã§ãç±³åœã®å¹³å寿åœã® ã壿» ç㪠ãäœäžãšããåé¡ã解決ããããã«ã瀟äŒå šäœã§ ãç·åãæã㊠ãåãçµãããåŒã³ãããç°äŸã®æçš¿ãè¡ã£ãã
JAMA Internal Medicineèªã仿åãã«çºè¡šãããšããã«ããã°ãç±³åœå šäœã®å¹³å寿åœã¯76æ³ã«ãŸã§èœã¡èŸŒãã§ãããé©ãã¹ãããšã«ãç·æ§ã®å¹³å寿åœã¯73æ³ã«ãŸã§èœã¡èŸŒãã§ããã
ããããã³ãŒãªãŒã¯ãFDAé·å®ã®æçš¿ã¯ããå«ç ãé£äºãæ ¢æ§çŸæ£ãå»çãåãäžãããã®ã§ããããCOVIDãè¡°éããŠä¹ ããçŸåšã§ãã人ã ã¯ç°åžžã«å€ãæ»äº¡ããŠãããããããå ¬è¡è¡çæ©é¢ãå»åŠäŒã¯æ²é»ããŠããã
FDAãšäž»æµã¡ãã£ã¢ã¯ãçåœä¿éºäŒç€Ÿãã2023å¹Žã®æåã®9ã«æéã«ã2019幎ã®åææããã15äž8000人å€ãã¢ã¡ãªã«äººãæ»äº¡ãããããããã®äºæãã¬ããããã¯ããéå°ãª ãæ»äº¡ã«èŠéã鳎ãããŠããããšããäºå®ãç¡èŠããŠããããšã³ãŒãªãŒã¯æžããŠããã
ãããã¯ããããã æŠäºä»¥éã®ãã¹ãŠã®æŠäºã§ã¢ã¡ãªã«ã被ã£ãç ç²è ã®åèšãäžåããã®ã ãè°äŒã¯ä¿éºã®å°éå®¶ãšååããŠããã®åä»ãªåŸåãæ©æ¥ã«èª¿æ»ãã¹ãã ã
ãã€ãªãŒã¯ã©ãŠãã®COOã§ããããã¡ã€ã¶ãŒææžåæãããžã§ã¯ãã®ããã°ã©ã ã»ãã£ã¬ã¯ã¿ãŒã§ãããšã€ããŒã»ã±ãªãŒã¯ãmRNAã¯ã¯ãã³ã«ããæ»äº¡ã®é©åãªèšºæã«è³ãè§£åã«ã¯ããå šèº«ã®çµç¹ã®ç ççµç¹åŠçæ€æ»ãå¿ èŠã§ããã忀ãè¡ããããšããŠããç ççµç¹åŠçæ€æ»ã¯è¡ãããªãããšãã»ãšãã©ã§ããã
圌女ã¯ã¢ã«ãã»ãã«ã¯ãã«ãå士ã®ã€ã³ã¿ãã¥ãŒãåŒçšããæ€èŠå®ãè¡ãªããªããã°ãªããªããããã£ãã«è¡ãªãããªãæ€æ»ã®çš®é¡ã«ã€ããŠè¿°ã¹ãŠããã
ããµã³ãŒã«ã¹ã®æŽåœ¢å€ç§å»ã§ãåã«ãªãã©ã«ãã¢å€§åŠå»åŠéšã§æéããšã£ãŠãããããŒãã»ãã£ã³ãã©ãŒå士ã¯ããã¡ã€ã¶ãŒç€Ÿã®45äžããŒãžã«ãåã¶COVID-19ã¯ã¯ãã³ã®ææžãã€ãŸãFDAãè£å€æåœä»€ã«ãã£ãŠå ¬éãäœåãªããããææžãç ç©¶ããŠã圌ã ãCoVax Diseases ããšåŒã¶ ãæ°ããç æ°ã®ã«ããŽãªãŒå šäœ ããç¹å®ããããšã±ãªãŒæ°ã¯èšãã
ãç¹å®äžèœã®æ»å ãããã»ã©å¢å ããã®ã¯çã«ããªã£ãŠããŸãããã£ã³ãã©ãŒå士ãç¹å®ãã ãCoVax Diseasesãã®ããã«ãæ£è ãäžåºŠã«è€æ°ã®ç æ°ã§æ»äº¡ãããã以åã«ã¯èŠãããªãã£ãç æ ã§æ»äº¡ããå Žåãå€ãã®å»åž«ãæ€èŠå®ã¯ãã®ãããªæ»å ãã©ã®ããã«åé¡ãããããã®ãåãããªãã®ã§ãããããããªããšãæ»å ã "äžæ "ã«åé¡ãããŠããŸãã®ã§ãã
ãç£ã«ç«ã¡åãããã®èè ãããªãã»ãŠã«ãã¯èšãïŒ ç£æ¥é©åœä»¥åã®äžçã§ã¯ã人ã ã¯è¬ã®æ»ãéããŠãããããããçŸä»£ã®è¥¿æ¬§äžçã§ã¯ãè¬ã®æ»ã¯ãªãããã¹ãŠã®æ»ã«ã¯æ»äº¡èšºææžããããæ³åŸã§æ»å ãç¹å®ããªããã°ãªããªãã
ãäºçްãªç¡æ»å æ»ã®å¢å ã¯èª¿æ»ãå¿ èŠãªåé¡ã§ããããªããææãããããªå€§å¹ ãªå¢å ã¯ãå»åž«ãç£å¯å»ã«ãšã£ãŠå€§éã®è¬ã瀺ããã®ã§ã¯ãªãããããå·ã®èšé²ç®¡çã«åé¡ããã蚌æ ã§ãããã